pyrroles has been researched along with pentagastrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, JW; Buck, IM; Cooke, T; Dunstone, DJ; Gaffen, JD; Griffin, EP; Harper, EA; Hull, RA; Kalindjian, SB; Lilley, EJ; Linney, ID; Low, CM; McDonald, IM; Pether, MJ; Roberts, SP; Shankley, NP; Shaxted, ME; Steel, KI; Sykes, DA; Tozer, MJ; Walker, MK; Watt, GF; Wright, L; Wright, PT | 1 |
| Krewer, B; Major, F; Panknin, O; Tietze, LF | 1 |
2 other study(ies) available for pyrroles and pentagastrin
| Article | Year |
|---|---|
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
Topics: Administration, Oral; Animals; Biological Availability; Cerebral Cortex; Dogs; Female; Gastric Acid; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Mice; Models, Molecular; Pentagastrin; Pyrroles; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Cholecystokinin B | 2005 |
Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy.
Topics: Antineoplastic Agents; Catalysis; Cell Proliferation; Drug Delivery Systems; Duocarmycins; Esters; Indoles; Molecular Structure; Palladium; Pentagastrin; Pyrroles; Receptor, Cholecystokinin B | 2008 |